Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.79T | 3.76T | 3.71T | 3.59T | 3.59T | 3.86T |
Gross Profit | 1.19T | 1.16T | 1.14T | 1.12T | 1.08T | 1.11T |
EBITDA | 461.19B | 370.73B | 457.57B | 446.38B | 471.68B | 447.69B |
Net Income | 267.00B | 254.48B | 215.18B | 182.69B | 202.70B | 160.04B |
Balance Sheet | ||||||
Total Assets | 3.46T | 3.51T | 3.27T | 3.33T | 3.19T | 3.19T |
Cash, Cash Equivalents and Short-Term Investments | 476.37B | 342.14B | 355.90B | 484.02B | 481.83B | 451.86B |
Total Debt | 283.44B | 245.68B | 211.18B | 285.32B | 316.32B | 405.57B |
Total Liabilities | 1.52T | 1.60T | 1.53T | 1.62T | 1.64T | 1.84T |
Stockholders Equity | 1.78T | 1.75T | 1.59T | 1.59T | 1.45T | 1.24T |
Cash Flow | ||||||
Free Cash Flow | 117.76B | 113.38B | 52.23B | 105.10B | 179.18B | 214.29B |
Operating Cash Flow | 314.70B | 309.22B | 220.33B | 248.35B | 307.95B | 347.26B |
Investing Cash Flow | -157.92B | -157.24B | -42.81B | -59.27B | -71.56B | -114.21B |
Financing Cash Flow | -163.27B | -181.49B | -313.58B | -193.69B | -219.63B | -193.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $78.03B | 24.28 | 29.00% | 2.78% | 3.85% | -0.38% | |
77 Outperform | $201.01B | 23.52 | 27.27% | 2.00% | 6.21% | 14.87% | |
77 Outperform | $44.29B | 30.12 | 11.70% | 0.46% | -10.11% | -14.62% | |
72 Outperform | $32.41B | 20.46 | 16.62% | 1.01% | -2.83% | 106.18% | |
71 Outperform | $38.32B | 16.37 | 16.61% | 1.59% | 4.09% | 14.05% | |
71 Outperform | $42.45B | 50.54 | 5.25% | 1.98% | -9.12% | ― | |
69 Neutral | ¥231.71B | 14.67 | 7.64% | 2.71% | 9.09% | 8.52% |